The Charlottesville, Virginia-based company expects to add an infectious disease test menu to its system using its proprietary extraction process.
Watchmaker Genomics Raises $40M in Series A Financing
The Boulder, Colorado-based sample preparation firm said it would use the funds for its protein-engineering platform and to grow its operations.
COVID-19 accelerated the growth of several product portfolios, but under CEO Thierry Bernard, the company is ready to put the pandemic behind it — mostly.
Emerging from stealth mode, the Toronto-based firm will use the platform to identify circulating tumor cells and spur drug development in the lung cancer space.
Baylor Genetics, Miraca Research Institute Explore EV Purification for Cancer-Based Applications
The group will validate Miraca's prototype extracellular vesicle isolation tool and antibody reagents using blood samples from breast and pancreatic patients.